轴突和树突中的淀粉样β降低局部棘突数量和可塑性。
Amyloid beta from axons and dendrites reduces local spine number and plasticity.
机构信息
Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
出版信息
Nat Neurosci. 2010 Feb;13(2):190-6. doi: 10.1038/nn.2476. Epub 2009 Dec 27.
Abstract
Excessive synaptic loss is thought to be one of the earliest events in Alzheimer's disease. Amyloid beta (Abeta), a peptide secreted in an activity-modulated manner by neurons, has been implicated in the pathogenesis of Alzheimer's disease by removing dendritic spines, sites of excitatory synaptic transmission. However, issues regarding the subcellular source of Abeta, as well as the mechanisms of its production and actions that lead to synaptic loss, remain poorly understood. In rat organotypic slices, we found that acute overproduction of either axonal or dendritic Abeta reduced spine density and plasticity at nearby ( approximately 5-10 mum) dendrites. The production of Abeta and its effects on spines were sensitive to blockade of action potentials or nicotinic receptors; the effects of Abeta (but not its production) were sensitive to NMDA receptor blockade. Notably, only 30-60 min blockade of Abeta overproduction permitted induction of plasticity. Our results indicate that continuous overproduction of Abeta at dendrites or axons acts locally to reduce the number and plasticity of synapses.
摘要
过度的突触损失被认为是阿尔茨海默病的最早事件之一。淀粉样β肽（Abeta）是一种由神经元以活性调节方式分泌的肽，通过去除树突棘（兴奋性突触传递的部位）而被牵连到阿尔茨海默病的发病机制中。然而，关于 Abeta 的亚细胞来源，以及导致突触损失的其产生和作用的机制，仍然知之甚少。在大鼠器官型切片中，我们发现急性过量产生轴突或树突 Abeta 都会降低附近（约 5-10 µm）树突上的棘密度和可塑性。Abeta 的产生及其对棘的作用对动作电位或烟碱型乙酰胆碱受体阻断敏感；Abeta 的作用（而不是其产生）对 NMDA 受体阻断敏感。值得注意的是，只有 30-60 分钟的 Abeta 过量产生阻断才能诱导可塑性。我们的结果表明，树突或轴突上 Abeta 的持续过量产生会局部作用于减少突触的数量和可塑性。
相似文献
1
Amyloid beta from axons and dendrites reduces local spine number and plasticity.轴突和树突中的淀粉样β降低局部棘突数量和可塑性。
Nat Neurosci. 2010 Feb;13(2):190-6. doi: 10.1038/nn.2476. Epub 2009 Dec 27.
2
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.神经递质受体和阿尔茨海默病 Aβ 在体内引起的突触可塑性破坏作用的时间依赖性。
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130147. doi: 10.1098/rstb.2013.0147. Print 2014 Jan 5.
3
NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.NMDA 受体介导突触抑制，但成年淀粉样β（Aβ）过表达小鼠齿状回中的棘突丢失不被介导。
Acta Neuropathol Commun. 2018 Oct 23;6(1):110. doi: 10.1186/s40478-018-0611-4.
4
Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability.NMDA受体在控制棘突和突触稳定性方面的独特结构和离子otropic作用。 （注：原文中ionotropic可能有误，推测正确单词为ionotropic，“离子otropic”，这里按照正确推测翻译了，若有误请根据实际情况调整）
J Neurosci. 2007 Jul 11;27(28):7365-76. doi: 10.1523/JNEUROSCI.0956-07.2007.
5
Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.阿尔茨海默病早期淀粉样变模型中海马 CA1 锥体神经元树突抑制减少。
J Alzheimers Dis. 2020;78(3):951-964. doi: 10.3233/JAD-200527.
6
Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.罗格列酮通过增加树突和棘突线粒体数量来预防淀粉样β寡聚体诱导的突触形成和可塑性损伤。
J Alzheimers Dis. 2014;39(2):239-51. doi: 10.3233/JAD-130680.
7
Synaptic Plasticity Depends on the Fine-Scale Input Pattern in Thin Dendrites of CA1 Pyramidal Neurons.突触可塑性取决于 CA1 锥体神经元薄树突中的精细输入模式。
J Neurosci. 2020 Mar 25;40(13):2593-2605. doi: 10.1523/JNEUROSCI.2071-19.2020. Epub 2020 Feb 11.
8
Neuronal activity regulates diffusion across the neck of dendritic spines.神经元活动调节树突棘颈部的扩散。
Science. 2005 Nov 4;310(5749):866-9. doi: 10.1126/science.1114816.
9
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.突触活动可减少神经元内的β淀粉样蛋白，促进淀粉样前体蛋白（APP）向突触的转运，并防止与β淀粉样蛋白相关的突触改变。
J Neurosci. 2009 Aug 5;29(31):9704-13. doi: 10.1523/JNEUROSCI.2292-09.2009.
10
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.非纤维状β淀粉样蛋白通过靶向突触后AMPA受体减弱新皮层2/3层兴奋性突触处的尖峰时间依赖性突触增强。
Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x.
引用本文的文献
1
Identification of TMED10 as A Regulator for Neuronal Exocytosis of Amyloid Beta 42.鉴定TMED10作为淀粉样β蛋白42神经元胞吐作用的调节因子。
Neurosci Bull. 2025 Sep 5. doi: 10.1007/s12264-025-01492-3.
2
Investigation into Efficacy and Mechanisms of Neuroprotection of Ashwagandha Root Extract and Water-Soluble Coenzyme Q10 in a Transgenic Mouse Model of Alzheimer's Disease.在阿尔茨海默病转基因小鼠模型中对南非醉茄根提取物和水溶性辅酶Q10神经保护作用的疗效及机制研究
Nutrients. 2025 Aug 20;17(16):2701. doi: 10.3390/nu17162701.
3
APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ.淀粉样前体蛋白β-羧基末端片段（APP β-CTF）引发不依赖于β-淀粉样蛋白（Aβ）的细胞自主突触毒性。
Elife. 2025 Apr 23;13:RP100968. doi: 10.7554/eLife.100968.
4
Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults.在认知未受损的成年人中，β淀粉样蛋白沉积可预测脑磁图信号的振荡减慢以及功能连接随时间的减少。
Brain Commun. 2025 Jan 20;7(1):fcaf018. doi: 10.1093/braincomms/fcaf018. eCollection 2025.
5
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.AMPA受体扩散捕获机制作为神经退行性疾病和神经精神疾病的早期治疗靶点。
Transl Neurodegener. 2025 Feb 11;14(1):8. doi: 10.1186/s40035-025-00470-z.
6
Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy.淀粉样β蛋白和tau蛋白磷酸化以及RhoA活性诱导阿尔茨海默病的分子机制：RhoA/ Rho相关蛋白激酶抑制剂用于神经元治疗的前景
Cells. 2025 Jan 10;14(2):89. doi: 10.3390/cells14020089.
7
Amyloid-β-Driven Synaptic Deficits Are Mediated by Synaptic Removal of GluA3-Containing AMPA Receptors.淀粉样β蛋白引发的突触缺陷是由含GluA3的AMPA受体的突触清除介导的。
J Neurosci. 2025 Feb 26;45(9):e0393242024. doi: 10.1523/JNEUROSCI.0393-24.2024.
8
Familial Alzheimer's disease mutations in amyloid precursor protein impair calcineurin signaling to NMDA receptors.淀粉样前体蛋白中的家族性阿尔茨海默病突变会损害钙调神经磷酸酶向N-甲基-D-天冬氨酸受体的信号传导。
J Biol Chem. 2025 Feb;301(2):108147. doi: 10.1016/j.jbc.2024.108147. Epub 2024 Dec 26.
9
Lateral Piezoelectricity of Alzheimer's Aβ Aggregates.阿尔茨海默病 Aβ 聚集物的横向压电性。
Adv Sci (Weinh). 2024 Oct;11(39):e2406678. doi: 10.1002/advs.202406678. Epub 2024 Aug 19.
10
Toll-like receptor 4 deficiency in Purkinje neurons drives cerebellar ataxia by impairing the BK channel-mediated after-hyperpolarization and cytosolic calcium homeostasis.浦肯野神经元中 Toll 样受体 4 的缺失通过损害 BK 通道介导的超极化后电位和细胞溶质钙稳态来驱动小脑共济失调。
Cell Death Dis. 2024 Aug 15;15(8):594. doi: 10.1038/s41419-024-06988-w.
本文引用的文献
1
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.一种用于测量阿尔茨海默病患者血浆和脑组织中β-淀粉样蛋白寡聚体的特异性酶联免疫吸附测定法。
Arch Neurol. 2009 Feb;66(2):190-9. doi: 10.1001/archneurol.2008.565.
2
Abeta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis.β淀粉样蛋白（1-42）减少原代皮质和海马神经元中的突触数量并抑制神经突生长：一项定量分析。
J Neurosci Methods. 2008 Oct 30;175(1):96-103. doi: 10.1016/j.jneumeth.2008.08.001. Epub 2008 Aug 9.
3
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.直接从阿尔茨海默病患者大脑中分离出的β-淀粉样蛋白二聚体损害突触可塑性和记忆。
Nat Med. 2008 Aug;14(8):837-42. doi: 10.1038/nm1782. Epub 2008 Jun 22.
4
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.含淀粉样β蛋白二聚体的人脑脊液会破坏突触可塑性：全身被动免疫可预防
J Neurosci. 2008 Apr 16;28(16):4231-7. doi: 10.1523/JNEUROSCI.5161-07.2008.
5
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.轻度认知障碍中的胆碱酯酶抑制剂：随机试验的系统评价
PLoS Med. 2007 Nov 27;4(11):e338. doi: 10.1371/journal.pmed.0040338.
6
Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein.自然分泌的淀粉样β蛋白诱导突触前和突触后结构的快速、同步改变。
Mol Cell Neurosci. 2007 Jun;35(2):183-93. doi: 10.1016/j.mcn.2007.02.006. Epub 2007 Feb 12.
7
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.阿尔茨海默病β淀粉样蛋白的天然寡聚体通过调节N-甲基-D-天冬氨酸（NMDA）型谷氨酸受体依赖性信号通路诱导可逆性突触丧失。
J Neurosci. 2007 Mar 14;27(11):2866-75. doi: 10.1523/JNEUROSCI.4970-06.2007.
8
Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.β淀粉样蛋白寡聚体引起的突触组成、形状和密度异常为阿尔茨海默病中连接性丧失提供了分子基础。
J Neurosci. 2007 Jan 24;27(4):796-807. doi: 10.1523/JNEUROSCI.3501-06.2007.
9
Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms.淀粉样前体蛋白的过表达通过突触前和突触后机制抑制兴奋性传递。
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):353-8. doi: 10.1073/pnas.0608807104. Epub 2006 Dec 21.
10
AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.AMPA受体的移除是β淀粉样蛋白诱导的突触抑制和树突棘丢失的基础。
Neuron. 2006 Dec 7;52(5):831-43. doi: 10.1016/j.neuron.2006.10.035.
Zotero 插件